Type 2 Diabetes Trial, Recruiting (NCT07225218)

Type 2 Diabetes Trial, Recruiting NCT07225218 Sponsor: University of California, Los Angeles Condition: Type 2 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT07225218 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 2 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are currently enrolled as an undergraduate student at UCLA (either full time or part time), have a BMI of 25 or higher (or 23 or higher for those who identify as Asian), and either have documented prediabetes or have been identified as high risk on a CDC health questionnaire

Who may not be able to join:

People who are not currently enrolled as an undergraduate student at UCLA (either full time or part time), or who do not meet the health criteria for the T-UP Wellness Program described above

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lauren E Wisk, PhD, University of California, Los Angeles

Phone: 310-267-5308

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07225218

Sponsor: University of California, Los Angeles

Phase: Not Applicable

Status: Recruiting

Condition: Type 2 Diabetes

Trial contact: 310-267-5308

More information: https://clinicaltrials.gov/study/NCT07225218

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are currently enrolled as an undergraduate student at UCLA (either full time or part time), have a BMI of 25 or higher (or 23 or higher for those who identify as Asian), and either have documented prediabetes or have been identified as high risk on a CDC health questionnaire

Who may not be able to join:

People who are not currently enrolled as an undergraduate student at UCLA (either full time or part time), or who do not meet the health criteria for the T-UP Wellness Program described above

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of California, Los Angeles

Registry

ClinicalTrials.gov

Start date

14 October 2025

Est. completion

1 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in weight (pounds, lbs) between baseline and 9-month follow-up; Change in self-reported quality of life (Centers for Disease Control and Prevention Health-Related Quality of Life-14 item (CDC HRQOL-14)) between baseline and 9-month follow-up

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov